Biotech Values

[DewDiligence]

Teva’s ItalFarmaco connection—below is an excerpt from Exhibit “B” (a letter from MNTA’s lawyer to Teva’s lawyer) in MNTA’s motion to the US District Court for expedited discovery (see page 27 of the pdf file in #msg-59484899):

“Finally, I understand from your letter that you believe that certain documents may be in possession of a third party in Italy. Please let us know the status of your investigation into the prompt availability of such documents including, in particular, batch records and certificates of testing and/or analysis for the manufacture of generic enoxaparin.”